Quoin Pharmaceuticals, Ltd. (QNRX)

NASDAQ: QNRX · Real-Time Price · USD

5.70

-0.03 (-0.52%)

At close: Apr 24, 2026, 4:00 PM EDT

5.40

-0.30 (-5.26%)

After-hours: Apr 24, 2026, 4:43 PM EDT

Quoin Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-15.8	-8.96	-8.69	-9.38	-21.46
Depreciation & Amortization	0.1	0.1	0.1	0.1	0.1
Other Amortization	-	-	-	-	0.28
Asset Writedown & Restructuring Costs	-	-	0.02	-	-
Loss (Gain) From Sale of Investments	-0.22	-0.25	-0.49	-0.09	-
Stock-Based Compensation	1.15	1.26	1.09	0.76	-
Other Operating Activities	-	-	-	0.22	14.73
Change in Accounts Payable	1.33	0.28	0.05	-0.22	1.35
Change in Other Net Operating Assets	-0.09	-0.28	0.04	0.12	-0.72
Operating Cash Flow	-13.54	-7.86	-7.86	-8.48	-5.72
Investment in Securities	-4.28	-1.89	2.19	-9.9	-
Other Investing Activities	-	-	-	-0.25	-0.63
Investing Cash Flow	-4.28	-1.89	2.19	-10.15	-0.63
Short-Term Debt Issued	-	-	-	-	3.48
Long-Term Debt Issued	-	-	-	-	0.14
Total Debt Issued	-	-	-	-	3.61
Short-Term Debt Repaid	-	-	-	-0.31	-
Long-Term Debt Repaid	-0.6	-0.6	-0.6	-0.6	-0.3
Total Debt Repaid	-0.6	-0.6	-0.6	-0.91	-0.3
Net Debt Issued (Repaid)	-0.6	-0.6	-0.6	-0.91	3.31
Issuance of Common Stock	18.61	11.57	5.85	14.88	10.1
Other Financing Activities	-	-	-0.03	0.04	0.09
Financing Cash Flow	18.01	10.97	5.22	14.01	13.5
Foreign Exchange Rate Adjustments	-0	-	-	-	-
Net Cash Flow	0.19	1.22	-0.46	-4.62	7.16
Cash Interest Paid	-	-	-	-	0.39
Levered Free Cash Flow	-7.96	-4.28	-4.68	-6.21	-7.63
Unlevered Free Cash Flow	-7.96	-4.28	-4.68	-5.77	-7.06
Change in Working Capital	1.23	-0	0.1	-0.09	0.63

Updated Mar 26, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q